verapamil has been researched along with bd 1047 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Akopova, I; Clark, AF; Daudt, DR; Ma, HY; Mueller, BH; Park, Y; Stankowska, DL; Yorio, T | 1 |
2 other study(ies) available for verapamil and bd 1047
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells.
Topics: Animals; Animals, Newborn; Blotting, Western; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Ethylenediamines; Fluorescent Antibody Technique, Indirect; Fura-2; Microscopy, Fluorescence; Pentazocine; Phenazocine; Rats; Rats, Sprague-Dawley; Receptors, sigma; Retinal Ganglion Cells; Sigma-1 Receptor; Verapamil | 2013 |